Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients

<div>Study design flowchart. NAFLD: nonalcoholic fatty liver disease; HOMA-IR: homeostatic model assessment for insulin resistance; TNF-<i>α</i>: tumor necrosis factor-alpha; HMGB-1: high mobility group box 1; TBARS: thiobarbituric acid reactive substances; EGFR: epidermal growth factor receptor; CD: cluster of differentiation; IL: interleukin; IGF: insulin growth factor; TGF-<i>β</i>: transforming growth factor-beta; MMP-2: metalloproteinase 2; FIB-4: fibrosis 4 index; NFS: NAFLD fibrosis score.</div>

Oxidative Medicine and Cellular Longevity

fig1

Figure 1

Figure 1: Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 

Figure 1 | Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 